LegalizeCommission Implementing Regulation (EU) 2025/243 of 30 January 2025 amending Annex I to Implementing Regulation (EU) 2021/403 as regards model animal health certificates for movements between Member States of consignments of certain categories of terrestrial animals and germinal products thereof
This is the act as published. Later amendments are not folded into the text below: each one is a separate act in this repository and an entry in this law's history.
I, the undersigned official veterinarian, hereby certify that: II.1. The ovine/caprine animals (1) of the consignment described in Part I meet the following requirements: II.1.1. They are identified as provided for in Article 45(2) or (4) or Article 46(1) of Commission Delegated Regulation (EU) 2019/2035. II.1.2. They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age: II.1.2.1. have been continuously resident in the establishment of origin; II.1.2.2. have not been in contact with kept ovine or caprine animals of a lower health status or subject to movement restrictions for animal health reasons; II.1.2.3. have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the consignment. II.1.3. They have not shown clinical signs or symptoms of diseases listed for ovine/caprine animals during the clinical examination which was carried out, within the last 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy). II.2. According to official information, the animals described in Part I meet the following health requirements: II.2.1. (2) either [They come from establishments or zones not subject to movement restrictions affecting ovine/caprine animals and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.] (2) or [They come from establishments or zones subject to movement restrictions affecting ovine/caprine animals and established for … (3), but derogations from movement restrictions have been granted, and: (2) [they comply with the requirements set out in … (4);]] (2) [and in particular, they are … (5).]] (2) either [II.2.2. They come from establishments free from infection with Brucella abortus, B. melitensis and B. suis without vaccination regarding ovine and caprine animals, and: (2) either [the establishments of origin are situated in a Member State or zone thereof with the status free from infection with Brucella abortus, B. melitensis and B. suis regarding the ovine and caprine population;]] (2) and/or [they have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure of the consignment, and in the case of post-parturient females taken at least 30 days after parturition;]] (2) and/or [they are less than 6 months old;]] (2) and/or [they are castrated.]] (2) or [II.2.2. They come from establishments free from infection with Brucella abortus, B. melitensis and B. suis with vaccination regarding ovine and caprine animals and they are moved to a Member State or zone thereof without the status free from infection with Brucella abortus, B. melitensis and B. suis regarding ovine and caprine animals.] (2) either [II.2.3. They are kept ovine animals and come from establishments in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has not been reported during the last 42 days prior to date of departure of the consignment.] (2) and/or [II.2.3. They are kept caprine animals and come from establishments in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the caprine animals kept in the establishments during at least 12 months prior to the date of departure of the consignment, as referred to in Article 15(3) of Delegated Regulation (EU) 2020/688.] II.2.4. They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment. II.2.5. They come from establishments situated in an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus: (2) either [has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Delegated Regulation (EU) 2020/688: (2) either [for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]] (2) and/or [for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688: (2) either [for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]] (2) and/or [for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and: (2) either [they have been vaccinated at least 60 days prior to the date of departure of the consignment;]] (2) and/or [they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;] (2) and [the requirements laid down in Article 15(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.] II.2.6. They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment. II.2.7. They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and (2) either [surra has not been reported in the establishments during the last 2 years prior to the date of departure of the consignment.] (2) or [surra has been reported during the last 2 years prior to the date of departure of the consignment, following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.] (2) [II.2.8. They are kept uncastrated male ovine animals, and: II.2.8.1. come from establishments in which ovine epididymitis (Brucella ovis) has not been reported during the last 12 months prior to the date of departure of the consignment, and II.2.8.2. have been subjected to a serological test for ovine epididymitis (Brucella ovis), carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure of the consignment.] (2) either [II.2.9. They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) within the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.] (2) and/or [II.2.9. They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they: (2) either [II.2.9.1. have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689: (2) either [II.2.9.1.1. for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.9.1.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]] (2) and/or [II.2.9.1.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]] (2) and/or [II.2.9.2. have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment; (2) either [II.2.9.2.1. for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.9.2.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]] (2) and/or [II.2.9.2.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]] (2) and/or [II.2.9.3. have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years in that Member State or zone thereof and are within the immunity period guaranteed in the specifications of the vaccine, and: (2) either [II.2.9.3.1. have been vaccinated more than 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.9.3.2. have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]] (2) and/or [II.2.9.4. have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported during the last 2 years prior to the date of departure of the consignment in that Member State or zone thereof, and: (2) either [II.2.9.4.1. the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.9.4.2. the serological test has been carried out on samples collected at least 30 days prior to the date of departure of the consignment and the animals have been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]] (2) and/or [II.2.9. They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and: (2) either [II.2.9.1. have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment: (2) either [II.2.9.1.1. for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.9.1.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]] (2) and/or [II.2.9.1.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]] (2) and/or [II.2.9.2. have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or in an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and: (2) either [II.2.9.2.1. the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept and are within the immunity period guaranteed in the specifications of the vaccine and: (2) either [II.2.9.2.1.1. have been vaccinated more than 60 days prior to the date of departure of the consignment;]]] (2) and/or [II.2.9.2.1.2. have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]] (2) and/or [II.2.9.2.2. the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment in an area of at least 150 km radius centred on the place where the animals were kept, and: (2) either [II.2.9.2.2.1. the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]] (2) and/or [II.2.9.2.2.2. the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of departure of the consignment and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]] (2) and/or [II.2.9. They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof: (2) either [II.2.9.1. with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and: (2) either [II.2.9.1.1. Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and (2) and/or [II.2.9.1.2. Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and (2) and/or [II.2.9.1.3. Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and (2) and/or [II.2.9.1.4. Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]] (2) and/or [II.2.9.2. with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised under the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and: (2) either [II.2.9.2.1. Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and (2) and/or [II.2.9.2.2. Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and (2) and/or [II.2.9.2.3. Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and (2) and/or [II.2.9.2.4. Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]] (2) and/or [II.2.9.3. neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised: (2) either [II.2.9.3.1. without any conditions, and (2) and/or [II.2.9.3.2. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and (2) and/or [II.2.9.3.3. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and (2) and/or [II.2.9.3.4. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689, and (2) and/or [II.2.9.3.5. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]] (2) either [II.2.10. The animals are intended for a Member State or zone thereof listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 of the European Parliament and of the Council as having a negligible risk status for classical scrapie or for a Member State listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme, and: (2) either [come from a holding situated in a Member State or zone thereof listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie;] (2) and/or [come from a holding recognised as having a negligible risk of classical scrapie in accordance with Chapter A, Section A, point 1.2, of Annex VIII to Regulation (EC) No 999/2001 and listed as such by the competent authority of the Member State in accordance with Chapter A, Section A, point 1.1, of Annex VIII to Regulation (EC) No 999/2001;] (2) and/or [come from a holding not subject to the measures laid down in Chapter B, points 3 and 4, of Annex VII to Regulation (EC) No 999/2001 and the animals are of the ovine species and are of the ARR/ARR prion protein genotype, or the animals are of the caprine species and carry at least one of the K222, D146 or S146 alleles;] (2) and/or [come from and are destined for a confined establishment as defined in Article 4, point (48), of Regulation (EU) 2016/429 of the European Parliament and of the Council;] (2) or [comply with the conditions set out in Chapter A, Section A, point 4.1(d), of Annex VIII to Regulation (EC) No 999/2001.]] (2) or [II.2.10. The animals are for breeding and are intended for a Member State or zone thereof other than those listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie or other than those listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme, and: (2) either [come from a holding situated in a Member State or zone of a Member State listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie;] (2) and/or [come from a holding recognised as having a negligible risk of classical scrapie in accordance with Chapter A, Section A, point 1.2, of Annex VIII to Regulation (EC) No 999/2001 and listed as such by the competent authority of the Member State in accordance with Chapter A, Section A, point 1.1, of Annex VIII to Regulation (EC) No 999/2001;] (2) and/or [come from a holding recognised as having a controlled risk of classical scrapie in accordance with Chapter A, Section A, point 1.3, of Annex VIII to Regulation (EC) No 999/2001 and listed as such by the competent authority of the Member State in accordance with Chapter A, Section A, point 1.1, of Annex VIII to Regulation (EC) No 999/2001;] (2) and/or [come from a holding not subject to the measures laid down in Chapter B, points 3 and 4, of Annex VII to Regulation (EC) No 999/2001 and the animals are of the ovine species and are of the ARR/ARR prion protein genotype, or the animals are of the caprine species and carry at least one of the K222, D146 or S146 alleles;] (2) and/or [come from and are destined for a confined establishment as defined in Article 4, point (48), of Regulation (EU) 2016/429;] (2) or [comply with the conditions set out in Chapter A, Section A, point 4.1(d), of Annex VIII to Regulation (EC) No 999/2001.]] (2) or [II.2.10. The animals are not for breeding and are intended for a Member State or zone thereof other than those listed in Chapter A, Section A, point 2.3, of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie or other than those listed in Chapter A, Section A, point 3.2, of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control programme.] II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause. II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688. II.5. This animal health certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea. (2) (6) [II.6. Since the date of departure from their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and (2) either [they come from their establishments of origin.]] (2) or [at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]] (2) or [at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]] Animal welfare attestation At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on … (insert date) (7) (8). Notes: In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429. Box reference I.12 : “Place of destination”: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429. Box reference I.17 : “Accompanying documents”: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated. In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, shall be indicated. Box reference I.30 : “Identification number”: Indicate identification codes of the animals in the consignment identified in accordance with Article 45(2) or (4) or Article 46(1) of Delegated Regulation (EU) 2019/2035. Part II: (1) There may be one or more animals in the consignment. (2) Delete if not applicable. (3) Insert the name of the disease(s). (4) Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements. (5) Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 126(1), points (b)(ii) and (iii), of Regulation (EU) 2016/429. (6) Applicable in case the consignment is dispatched from the establishment approved for assembly operations. (7) In the case where a consignment is grouped in an establishment approved for assembly operations and comprises animals that were loaded on different dates, the date which the journey commenced for the whole consignment is considered to be the earliest date when any part of the consignment left the establishment of origin. (8) This statement does not exempt transporters from their obligation in accordance with Union rules in force in particular regarding the fitness to be transported.
Official veterinarian Official veterinarian Official veterinarian Official veterinarian Name (in capital letters) Qualification and title Local Control Unit name Local Control Unit code Date Stamp Signature’
;
- (3) Chapter 9 is replaced by the following:
‘CHAPTER 9
MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF CAMELID ANIMALS NOT INTENDED FOR SLAUGHTER (MODEL “CAM-INTRA-X”)
Part I: Description of consignment
EUROPEAN UNION INTRA
I.1 Consignor I.2 IMSOC reference Name I.2a Local reference Address I.3 Central Competent Authority QR CODE Address I.3 Central Competent Authority Country ISO country code I.4 Local Competent Authority I.5 Consignee I.6 Operator conducting assembly operations independently of an establishment Operator conducting assembly operations independently of an establishment Operator conducting assembly operations independently of an establishment Name Name Name Registration No Address Address Address Country ISO country code Country Country ISO country code I.7 Country of origin ISO country code I.9 Country of destination Country of destination ISO country code I.8 Region of origin Code I.10 Region of destination Region of destination Code I.11 Place of dispatch I.12 Place of destination Place of destination Name Registration/Approval No Name Name Registration/Approval No Address Address Address Country ISO country code Country Country ISO country code I.13 Place of loading Place of loading I.14 Date and time of departure Date and time of departure Date and time of departure
I.15 Means of transport I.16 Transporter Transporter ☐ Vessel ☐ Aircraft Name Registration/Authorisation No ☐ Vessel ☐ Aircraft Address ☐ Railway ☐ Road vehicle Country ISO country code ☐ Railway ☐ Road vehicle I.17 Accompanying documents Accompanying documents Identification ☐ Other Type Code Document Document Country ISO country code Document Document Commercial document reference
I.18 Transport conditions ☐ Ambient ☐ Chilled ☐ Frozen I.19 Container number/Seal number Container number/Seal number Container number/Seal number Container number/Seal number Container No Container No Seal No
I.20 Certified as or for Certified as or for Certified as or for Certified as or for ☐ Further keeping ☐ Further keeping ☐ Slaughter ☐ Confined establishment ☐ Germinal products ☐ Registered equine animal ☐ Registered equine animal ☐ Travelling circus/animal act ☐ Exhibition ☐ Event or activity near borders ☐ Release into the wild ☐ Release into the wild ☐ Dispatch centre ☐ Relaying area/purification centre ☐ Ornamental aquaculture establishment ☐ Further processing ☐ Further processing ☐ Organic fertilizers and soil improvers ☐ Technical use ☐ Quarantine or similar establishment ☐ Products for human consumption ☐ Products for human consumption ☐ Pollination ☐ Live aquatic animals for human consumption ☐ Other
I.21 ☐ For transit through a third country ☐ For transit through a third country Third country ISO country code Exit point BCP code Entry point BCP code
I.22 ☐ For transit through Member State(s) ☐ For transit through Member State(s) I.23 ☐ For export ☐ For export Member State ISO country code Third country ISO country code Member State ISO country code Exit point BCP code Member State ISO country code
I.24 Estimated journey time I.25 Journey log ☐ yes ☐ no I.26 Total number of packages I.27 Total quantity Total quantity Total quantity I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment Total space foreseen for the consignment Total space foreseen for the consignment
I.30 Description of consignment Description of consignment Description of consignment Description of consignment Description of consignment Description of consignment Description of consignment Description of consignment CN code CN code Species Subspecies/Category Sex Identification system Identification number Age Quantity Type Region of origin Region of origin Cold store Identification mark Type of packaging Net weight Slaughterhouse Slaughterhouse Treatment type Nature of commodity Number of packages Batch No Date of collection/production Manufacturing plant Approval or registration number of plant/establishment/centre Test
Part II: Certification
EUROPEAN UNION EUROPEAN UNION Certificate model CAM-INTRA-X Certificate model CAM-INTRA-X Certificate model CAM-INTRA-X Certificate model CAM-INTRA-X II. Health information II.a Certificate reference II.b IMSOC reference
I, the undersigned official veterinarian, hereby certify that: II.1. The camelid animals (1) of the consignment described in Part I meet the following requirements: II.1.1. They are identified as provided for in Article 73 of Commission Delegated Regulation (EU) 2019/2035. II.1.2. They, for at least 30 days prior to the date of departure of the consignment, or since birth, if they are younger than 30 days of age: II.1.2.1. have been continuously resident in the establishment of origin; II.1.2.2. have not been in contact with kept camelid animals of a lower health status or subject to movement restrictions for animal health reasons; II.1.2.3. have not been in direct or indirect contact with kept animals that have entered the Union from a third country or territory during the last 30 days prior to the date of departure of the consignment. II.1.3. They have not shown clinical signs or symptoms of diseases listed for camelid animals during the clinical examination which was carried out, within the last 24 hours prior to the time of departure of the consignment, on … (insert date dd/mm/yyyy). II.2. According to official information, the animals described in Part I meet the following health requirements: II.2.1. (2) either [They come from establishments or zones not subject to movement restrictions affecting camelid animals and established for reasons of diseases listed for those species or diseases subject to emergency measures relevant for those species, and they have not been in contact with kept animals of a listed species of a lower health status for an adequate period.] (2) or [They come from establishments or zones subject to movement restrictions affecting camelid animals and established for … (3), but derogations from movement restrictions have been granted, and: (2) [they comply with the requirements set out in … (4);]] (2) [and in particular, they are … (5).]] II.2.2. They come from establishments in which infection with Brucella abortus, B. melitensis and B. suis in camelid animals has not been reported during the last 42 days prior to the date of departure of the consignment, and the animals of the consignment have been subjected to a test for infection with Brucella abortus, B. melitensis and B. suis with one of the diagnostic methods provided for in Part 1 of Annex I to Commission Delegated Regulation (EU) 2020/688, carried out, with negative results, on a sample taken during the last 30 days prior to the date of departure of the consignment, and in the case of post-parturient females taken at least 30 days after parturition. II.2.3. They come from establishments in which surveillance for infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. tuberculosis) has been carried out on the camelid animals kept in the establishments during at least 12 months prior to the date of departure of the consignment, as referred to in Article 23(1), point (e), of Delegated Regulation (EU) 2020/688. II.2.4. They come from establishments in which infection with rabies virus in kept terrestrial animals has not been reported during the last 30 days prior to the date of departure of the consignment. II.2.5. They come from establishments situated within an area of at least 150 km radius around those establishments in which infection with epizootic haemorrhagic disease virus: (2) either [has not been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment;] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure and the animals have been kept in a zone seasonally free from epizootic haemorrhagic disease in accordance with Parts 1 and 2 of Annex IX to Delegated Regulation (EU) 2020/688: (2) either [for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the seasonally disease-free area;]] (2) and/or [for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the seasonally disease-free area;]] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure and the animals have been protected against attacks by vectors during transportation to the place of destination and they have been kept protected against attacks by vectors in a vector protected establishment fulfilling the requirements provided for in Part 3 of Annex IX to Delegated Regulation (EU) 2020/688: (2) either [for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]] (2) and/or [for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of commencement of the period of protection against attacks by vectors;]] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals have been vaccinated against infection with epizootic haemorrhagic disease virus and the animals are within the immunity period guaranteed in the specifications of the vaccine and: (2) either [they have been vaccinated at least 60 days prior to the date of departure of the consignment;]] (2) and/or [they have been vaccinated with an inactivated vaccine and have been subject to a PCR test, with negative results on samples collected at least 14 days after the onset of the immunity set in the specifications of the vaccine;]] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;] (2) and/or [has been reported in kept animals of listed species for that disease during the last 2 years prior to the date of departure of the consignment and the animals comply with specific risk-mitigating measures defined by the competent authority of the Member State of destination and the Member State of destination has informed the Commission and the other Member States that such movement is authorised;] (2) and [the requirements laid down in Article 23(1), third subparagraph, of Delegated Regulation (EU) 2020/688 are fulfilled.] II.2.6. They come from establishments in which anthrax in ungulates has not been reported during the last 15 days prior to the date of departure of the consignment. II.2.7. They come from establishments in which surra (Trypanosoma evansi) has not been reported during the last 30 days prior to the date of departure of the consignment, and (2) either [surra has not been reported in the establishments during the last 2 years prior to the date of departure of the consignment.] (2) or [surra has been reported during the last 2 years prior to the date of departure of the consignment, and following the date of the last outbreak, the affected establishments have remained under movement restrictions until the date on which the infected animals have been removed from the establishments, and the remaining animals in the establishments have been subjected to a test for surra with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated Regulation (EU) 2020/688, carried out, with negative results, on samples taken at least 6 months following the date on which the infected animals have been removed from the establishments.] (2) either [II.2.8. They originate from a Member State or a zone thereof free from infection with bluetongue virus (serotypes 1-24), where no case of infection with bluetongue virus (serotypes 1-24) has been confirmed in the targeted animal population during the last 24 months prior to the date of departure of the consignment and have not been vaccinated with a live vaccine against infection with bluetongue virus (serotypes 1-24) within the last 60 days prior to the date of departure of the consignment and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled.] (2) and/or [II.2.8. They originate from a Member State or a zone thereof covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and: (2) either [II.2.8.1. have been kept in a Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24) in accordance with Article 40(3) of Commission Delegated Regulation (EU) 2020/689: (2) either [II.2.8.1.1. for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.8.1.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]] (2) and/or [II.2.8.1.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of entry of the animals into the Member State or zone thereof seasonally free from infection with bluetongue virus (serotypes 1-24);]]] (2) and/or [II.2.8.2. have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment: (2) either [II.2.8.2.1. for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.8.2.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]] (2) and/or [II.2.8.2.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]] (2) and/or [II.2.8.3. have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the departure of the consignment in that Member State or zone thereof and are within the immunity period guaranteed in the specifications of the vaccine, and: (2) either [II.2.8.3.1. have been vaccinated more than 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.8.3.2. have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results, carried out on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]] (2) and/or [II.2.8.4. have been subjected with positive results to a serological test able to detect specific antibodies against all serotypes 1-24 of infection with bluetongue virus reported during the last 2 years prior to the date of departure of the consignment in that Member State or zone thereof, and: (2) either [II.2.8.4.1. the serological test has been carried out on samples collected at least 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.8.4.2. the serological test has been carried out on samples collected at least 30 days prior to the date of the departure of the consignment and the animal has been subjected to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]] (2) and/or [II.2.8. They originate from a Member State or a zone thereof neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and: (2) either [II.2.8.1. have been protected against attacks by vectors during transportation to the place of destination and have been kept protected against attacks by vectors in a vector protected establishment: (2) either [II.2.8.1.1. for at least 60 days prior to the date of departure of the consignment;]] (2) and/or [II.2.8.1.2. for at least 28 days prior to the date of departure of the consignment and have been subjected to a serological test, with negative results, carried out on samples collected at least 28 days following the date of the commencement of the period of protection against attacks by vectors;]] (2) and/or [II.2.8.1.3. for at least 14 days prior to the date of departure of the consignment and have been subjected to a PCR test, with negative results, carried out on samples collected at least 14 days following the date of the commencement of the period of protection against attacks by vectors;]]] (2) and/or [II.2.8.2. have been kept for the last 60 days prior to the date of departure of the consignment in an establishment situated in a Member State or within an area of at least 150 km radius centred on the establishment, where surveillance in compliance with the requirements set out in Part II, Chapter 1, Sections 1 and 2, of Annex V to Delegated Regulation (EU) 2020/689 has been carried out during that period, and: (2) either [II.2.8.2.1. the animals have been vaccinated against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of the departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept, and are within the period of immunity guaranteed in the specifications of the vaccine, and: (2) either [II.2.8.2.1.1. have been vaccinated more than 60 days prior to the date of departure of the consignment;]]] (2) and/or [II.2.8.2.1.2. have been vaccinated with an inactivated vaccine and subjected to a PCR test, with negative results on samples collected at least 14 days after the date of the onset of the immunity set in the specifications of the vaccine;]]]] (2) and/or [II.2.8.2.2. the animals have been immunised against all serotypes 1-24 of infection with bluetongue virus which were reported during the last 2 years prior to the date of departure of the consignment within an area of at least 150 km radius centred on the place where the animals were kept, and: (2) either [II.2.8.2.2.1. the animals have been subjected with positive results to a serological test carried out on samples collected at least 60 days prior to the date of departure of the consignment;]]] (2) and/or [II.2.8.2.2.2. the animals have been subjected with positive results to a serological test carried out on samples collected at least 30 days prior to the date of departure of the consignment and to a PCR test, with negative results, carried out on samples collected not earlier than 14 days prior to the date of departure of the consignment;]]]] (2) and/or [II.2.8. They do not fulfil the requirements laid down in Part II, Chapter 2, Section 1, points 1 to 3, of Annex V to Delegated Regulation (EU) 2020/689 and the competent authority of the Member State of origin authorised movement of those animals to another Member State or zone thereof: (2) either [II.2.8.1. with the status free from infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689, and: (2) either [II.2.8.1.1. Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and (2) and/or [II.2.8.1.2. Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and (2) and/or [II.2.8.1.3. Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and (2) and/or [II.2.8.1.4. Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled]]] (2) and/or [II.2.8.2. with an approved eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised subject to the conditions referred to in Article 43(2), points (a), (b) and (c), of Delegated Regulation (EU) 2020/689 and: (2) either [II.2.8.2.1. Part II, Chapter 2, Section 1, point 5, of Annex V to that Delegated Regulation, and (2) and/or [II.2.8.2.2. Part II, Chapter 2, Section 1, point 6, of Annex V to that Delegated Regulation, and (2) and/or [II.2.8.2.3. Part II, Chapter 2, Section 1, point 7, of Annex V to that Delegated Regulation, and (2) and/or [II.2.8.2.4. Part II, Chapter 2, Section 1, point 8, of Annex V to that Delegated Regulation, and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled;]]] (2) and/or [II.2.8.2. neither free from infection with bluetongue virus (serotypes 1-24) nor covered by the eradication programme for infection with bluetongue virus (serotypes 1-24) and the Member State of destination has informed the Commission and the other Member States that such movement is authorised: (2) either [II.2.8.2.1. without any conditions, and (2) and/or [II.2.8.2.2. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 5, of Annex V to Delegated Regulation (EU) 2020/689, and (2) and/or [II.2.8.2.3. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 6, of Annex V to Delegated Regulation (EU) 2020/689, and (2) and/or [II.2.8.2.4. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 7, of Annex V to Delegated Regulation (EU) 2020/689, and (2) and/or [II.2.8.2.5. subject to the conditions referred to in Part II, Chapter 2, Section 1, point 8, of Annex V to Delegated Regulation (EU) 2020/689, and the requirements laid down in Article 32(1), point (a), (b) or (c), or Article 32(2) of Delegated Regulation (EU) 2020/688 and the requirements laid down in Article 33 of that Delegated Regulation are fulfilled.]]] (2) [II.2.9. They are moved to a Member State or zone thereof with the status free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis or with an approved eradication programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine animals and they come from an establishment in which infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in camelid animals has not been reported during the last 30 days prior to the date of departure of the consignment.] II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments where there were no abnormal mortalities with an undetermined cause. II.4. Arrangements are made to transport the consignment in accordance with Article 4 of Delegated Regulation (EU) 2020/688. II.5. This animal health certificate is valid for 10 days from the date of issuing. In the case of transport by waterway/sea of animals, the period of validity of the certificate may be extended by the duration of the journey by waterway/sea. (2) (6) [II.6. Since the date of departure from their establishments of origin and prior to the date of arrival to this establishment approved for assembly operations, none of the animals of the consignment has undergone more than two assembly operations, and (2) either [they come from their establishments of origin.]] (2) or [at least one of the animals of the consignment has undergone one assembly operation in an approved establishment.]] (2) or [at least one of the animals of the consignment has undergone two assembly operations in the approved establishments.]] Animal welfare attestation At the time of inspection, the animals covered by this animal health certificate were fit to be transported in accordance with the provisions of Council Regulation (EC) No 1/2005 on the intended journey due to start on … (insert date). Notes: In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Windsor Framework (see Joint Declaration No 1/2023 of the Union and the United Kingdom in the Joint Committee established by the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community of 24 March 2023, OJ L 102, 17.4.2023, p. 87) in conjunction with Annex 2 to that Framework, references to the Union in this animal health certificate include the United Kingdom in respect of Northern Ireland. This animal health certificate shall be completed in accordance with the notes for the completion of certificates provided for in Chapter 2 of Annex I to Commission Implementing Regulation (EU) 2020/2235. Part I: Box reference I.11 : “Place of dispatch”: Indicate an establishment of the origin of the animals in the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429 of the European Parliament and of the Council. Box reference I.12 : “Place of destination”: Indicate an establishment of the final destination of the consignment or an establishment approved for assembly operations in accordance with Articles 97 and 99 of Regulation (EU) 2016/429. Box reference I.17 : “Accompanying documents”: In case the animals are dispatched from an establishment approved for assembly operations in the Member State of origin, the reference number(s) of the official document(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, may be indicated. In case the animals are dispatched from an establishment approved for assembly operations in the Member State of passage, the reference number(s) of the certificate(s), based on which the animal health certificate for this consignment is issued in this establishment approved for assembly operations, shall be indicated. Box reference I.30 : “Identification number”: Indicate identification codes of the animals in the consignment identified in accordance with Article 73 of Delegated Regulation (EU) 2019/2035. Part II: (1) There may be one or more animals in the consignment. (2) Delete if not applicable. (3) Insert the name of the disease(s). (4) Insert the specific reference to the article(s), title, and number of the relevant legal act(s) adopted by the Commission providing for those requirements. (5) Insert the specific attestation(s) provided for in and required by the relevant legal act(s) adopted by the Commission, as referred to in Article 126(1), points (b)(ii) and (iii), of Regulation (EU) 2016/429. (6) Applicable in case the consignment is dispatched from the establishment approved for assembly operations.
Official veterinarian Official veterinarian Official veterinarian Official veterinarian Name (in capital letters) Qualification and title Local Control Unit name Local Control Unit code Date Stamp Signature’
;
- (4) Chapter 11 is replaced by the following:
‘CHAPTER 11
MODEL ANIMAL HEALTH CERTIFICATE FOR THE MOVEMENT BETWEEN MEMBER STATES OF CERVID ANIMALS NOT INTENDED FOR SLAUGHTER (MODEL “CER-INTRA-X”)
Part I: Description of consignment
EUROPEAN UNION INTRA
I.1 Consignor I.2 IMSOC reference Name I.2a Local reference Address I.3 Central Competent Authority QR CODE Address I.3 Central Competent Authority Country ISO country code I.4 Local Competent Authority I.5 Consignee I.6 Operator conducting assembly operations independently of an establishment Operator conducting assembly operations independently of an establishment Operator conducting assembly operations independently of an establishment Name Name Name Registration No Address Address Address Country ISO country code Country Country ISO country code I.7 Country of origin ISO country code I.9 Country of destination Country of destination ISO country code I.8 Region of origin Code I.10 Region of destination Region of destination Code I.11 Place of dispatch I.12 Place of destination Place of destination Name Registration/Approval No Name Name Registration/Approval No Address Address Address Country ISO country code Country Country ISO country code I.13 Place of loading Place of loading I.14 Date and time of departure Date and time of departure Date and time of departure
I.15 Means of transport I.16 Transporter Transporter ☐ Vessel ☐ Aircraft Name Registration/Authorisation No ☐ Vessel ☐ Aircraft Address ☐ Railway ☐ Road vehicle Country ISO country code ☐ Railway ☐ Road vehicle I.17 Accompanying documents Accompanying documents Identification ☐ Other Type Code Document Document Country ISO country code Document Document Commercial document reference
I.18 Transport conditions ☐ Ambient ☐ Chilled ☐ Frozen I.19 Container number/Seal number Container number/Seal number Container number/Seal number Container number/Seal number Container No Container No Seal No
I.20 Certified as or for Certified as or for Certified as or for Certified as or for ☐ Further keeping ☐ Further keeping ☐ Slaughter ☐ Confined establishment ☐ Germinal products ☐ Registered equine animal ☐ Registered equine animal ☐ Travelling circus/animal act ☐ Exhibition ☐ Event or activity near borders ☐ Release into the wild ☐ Release into the wild ☐ Dispatch centre ☐ Relaying area/purification centre ☐ Ornamental aquaculture establishment ☐ Further processing ☐ Further processing ☐ Organic fertilizers and soil improvers ☐ Technical use ☐ Quarantine or similar establishment ☐ Products for human consumption ☐ Products for human consumption ☐ Pollination ☐ Live aquatic animals for human consumption ☐ Other
I.21 ☐ For transit through a third country ☐ For transit through a third country Third country ISO country code Exit point BCP code Entry point BCP code
I.22 ☐ For transit through Member State(s) ☐ For transit through Member State(s) I.23 ☐ For export ☐ For export Member State ISO country code Third country ISO country code Member State ISO country code Exit point BCP code Member State ISO country code
I.24 Estimated journey time I.25 Journey log ☐ yes ☐ no I.26 Total number of packages I.27 Total quantity Total quantity Total quantity I.28 Total net weight/gross weight (kg) I.29 Total space foreseen for the consignment Total space foreseen for the consignment Total space foreseen for the consignment
I.30 Description of consignment Description of consignment Description of consignment Description of consignment Description of consignment Description of consignment Description of consignment Description of consignment CN code CN code Species Subspecies/Category Sex Identification system Identification number Age Quantity Type Region of origin Region of origin Cold store Identification mark Type of packaging Net weight Slaughterhouse Slaughterhouse Treatment type Nature of commodity Number of packages Batch No Date of collection/production Manufacturing plant Approval or registration number of plant/establishment/centre Test
Part II: Certification
Reading this document does not replace reading the official text published in the Official Journal of the European Union. We assume no responsibility for any inaccuracies arising from the conversion of the original to this format.
This text is published under EUR-Lex's own terms of reuse, not a Legalize or public-domain licence.
EUR-Lex
Creative Commons Attribution 4.0 International (CC BY 4.0)
© European Union, https://eur-lex.europa.eu — Source: EUR-Lex (Publications Office of the European Union). Reused under the Creative Commons Attribution 4.0 International (CC BY 4.0) licence. Only EU legislation published in the printed Official Journal of the European Union is deemed authentic; consolidated texts are reproduced here for documentation purposes and have been reformatted to Markdown.